Heparins in sepsis-induced disseminated intravascular coagulation: Low weight - high impact?

Critical Care Medicine

Volumn 33, Issue 6, 2005, Pages 1455-1457

  Lehmann, Christian ^a   Usichenko, Taras I ^a   Pavlovic, Dragan ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Coagulation; Disseminated intravascular coagulation; Inflammation; Low molecular weight heparin; Organ failure; Sepsis

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR; LIPOPOLYSACCHARIDE; LOW MOLECULAR WEIGHT HEPARIN; TISSUE FACTOR PATHWAY INHIBITOR;

BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TIME; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFECT; DRUG MECHANISM; EDITORIAL; FIBRINOLYSIS; GRANULOCYTE; HOMEOSTASIS; HUMAN; INFLAMMATION; MICROVASCULATURE; MONOCYTE; MULTIPLE ORGAN FAILURE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SEPSIS; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ANIMALS; ANTICOAGULANTS; DISSEMINATED INTRAVASCULAR COAGULATION; HEPARIN, LOW-MOLECULAR-WEIGHT; MICE; MULTIPLE ORGAN FAILURE;

EID: 20444486951     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000166703.33220.2D     Document Type: Editorial

References (18)

1. Jagneaux T, Taylor DE, Kantrow SP: Coagulation in sepsis. Am J Med Sci 2004; 328: 196-204
2. Amaral A, Opal SM, Vincent JL: Coagulation in sepsis. Intensive Care Med 2004; 30: 1032-40
3. Kinasewitz GT, Yan SB, Basson B, et al: Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative microorganism. Crit Care 2004; 8:R82-R90
4. Levi M, de Jonge E, van der Poll T: Sepsis and disseminated intravascular coagulation. J Thromb Thrombolysis 2003; 16:43-47
5. Shimamura K, Oka K, Nakazawa M, et al: Distribution patterns of microthrombi in disseminated intravascular coagulation. Arch Pathol Lab Med 1983; 107:543-547
6. Scherer RU, Giebler RM, Schmidt U, et al: Short-time rabbit model of endotoxin-induced hypercoagulability. Lab Anim Sci 1995; 45:538-546
7. Dhainaut JF, Yan SB, Joyce DE, et al: Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J Thromb Haemost 2004; 2:1924-1933
8. Freeman BD, Zehnbauer BA, Buchman TG: A meta-analysis of controlled trials of anticoagulant therapies in patients with sepsis. Shock 2003; 20:5-9
9. Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709
10. Slofstra SH, van't Veer C, Buurman WA, et al: Low molecular weight heparin attenuates multiple organ failure in a murine model of disseminated intravascular coagulation. Crit Care Med 2005; 33:1365-1370
11. Derhaschnig U, Pernerstorfer T, Knechtelsdorfer M, et al: Evaluation of antiinflammatory and antiadhesive effects of heparins in human endotoxemia. Crit Care Med 2003; 31:1108-1112
12. Elsayed E, Becker RC: The impact of heparin compounds on cellular inflammatory responses: A construct for future investigation and pharmaceutical development. J Thromb Thrombolysis 2003; 15:11-18
13. Lisman T, Adelmeijer J, Nieuwenhuis HK, et al: Enhancement of fibrinolytic potential in vitro by anticoagulant drugs targeting activated factor X, but not by those inhibiting thrombin or tissue factor. Blood Coagul Fibrinolysis 2003; 14:557-562
14. Opal SM, Esmon CT: Bench-to-bedside review: Functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis. Crit Care 2003; 7:23-38
15. Esmon CT: Interactions between the innate immune and blood coagulation systems. Trends Immunol 2004; 25:536-542
16. Taylor FB Jr, Chang ACK, Peer GT, et al: DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage. Blood 1991; 78:364-368
17. Riewald M, Ruf W: Science review: Role of coagulation protease cascades in sepsis. Crit Care 2003; 7:123-129
18. Cosmi B, Fredenburgh JC, Rischke J, et al: Effect of nonspecific binding to plasma proteins on the antithrombin activities of unfractionated heparin, low-molecular-weight heparin, and dermatan sulfate. Circulation. 1997; 95:118-24